Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common gout drug protect hearts from viral inflammation?

NCT ID NCT05855746

First seen Feb 28, 2026 · Last updated May 01, 2026 · Updated 5 times

Summary

This study tests whether colchicine, an anti-inflammatory drug, can reduce heart scarring and prevent serious complications in people with acute myocarditis (heart inflammation, often from a virus). About 300 participants will receive either colchicine or a placebo for six months. The goal is to see if colchicine lowers the risk of heart failure, dangerous heart rhythms, or the need for a heart transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institut de Cardiologie - APHP Pitié Salpêtrière

    RECRUITING

    Paris, 75013, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Unité de Soins Intensifs Cardiologiques - Hôpital Cardiovasculaire Louis Pradel

    RECRUITING

    Bron, 69029, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.